GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

FSBW · Mar 31, 2025

FS Bancorp, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001437749-25-015847Bank
Sequential deposit growth95thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

11.79% · CORE · VALID

Net-income growth30thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

-4.48% · CORE · VALID

Interest-income growth25thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

4.25% · CORE · VALID

Cash and equivalents60thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$62.7M · CORE · VALID

Sequential loan growth10thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

-0.03% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History57 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Increased
Previous
-3.62%
Current
11.79%
Delta
15.41%
Earnings Growth Decreased
Previous
-2.85%
Current
-4.48%
Delta
-1.62%
Interest Income Growth Decreased
Previous
10.55%
Current
4.25%
Delta
-6.30%
Liquidity Increased
Previous
$31.6M
Current
$62.7M
Delta
$31.1M
Loan Growth Decreased
Previous
1.55%
Current
-0.03%
Delta
-1.59%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.